Biotricity Inc. announced it has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists' patient use - Bioflux® and BiotresTM. The distribution agreement covers Bioflux and Biotres and will be distributed directly to hospitals and clinics for professional medical utilization with suitable patients.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | -3.77% | -6.42% | -11.30% |
Apr. 26 | Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro | CI |
Apr. 19 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-11.30% | 9.66M | |
-13.48% | 2.88B | |
+3.63% | 188M | |
+13.04% | 50.96M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. Signs Distribution Agreement with Top 5 Distributor for Its Cardiac Monitoring Solutions